tradingkey.logo
tradingkey.logo
Search

Abcellera Biologics Inc

ABCL
Add to Watchlist
5.715USD
+0.025+0.44%
Close 07-31 16:00ETQuotes delayed by 15 min
1.74BMarket Cap
LossP/E TTM

ABCL Financials

See Abcellera Biologics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Abcellera Biologics Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/-0.14
Revenue / Forecast
--/7.78M
Period
FY2025 Earnings
Revenue(YoY)
75.13M
160.56%
EPS(YoY)
-0.49
11.42%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
7.07%-0.14
74.22%-0.03
-10.26%-0.19
7.31%-0.12
-10.47%-0.15
28.70%-0.12
-75.38%-0.17
-18.78%-0.13
0.47%-0.14
-55.49%-0.16
---0.10
---0.11
---0.14
---0.10
--0.66
----
----
----
----
----
Revenue
96.34%8.31M
788.18%44.85M
37.62%8.96M
133.29%17.08M
-57.45%4.24M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-57.40%9.18M
-93.49%6.60M
-78.10%10.06M
-96.15%12.19M
-84.54%21.55M
1740.65%101.38M
66.11%45.92M
56.15%316.58M
-32.98%139.33M
--5.51M
146.20%27.64M
Net Profit
5.38%-43.16M
73.85%-8.95M
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.53%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
-134.66%-2.32M
Net Margin
51.81%-519.12%
97.06%-19.94%
18.79%-637.84%
59.69%-203.27%
-164.04%-1077.24%
-31.88%-677.43%
-81.16%-785.42%
-66.12%-504.30%
-24.01%-407.98%
-270.22%-513.67%
---433.55%
---303.58%
---328.99%
---138.75%
--40.62%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
----
Revenue
96.34%8.31M
788.18%44.85M
37.62%8.96M
133.29%17.08M
-57.45%4.24M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-57.40%9.18M
-93.49%6.60M
-78.10%10.06M
-96.15%12.19M
-84.54%21.55M
1740.65%101.38M
66.11%45.92M
56.15%316.58M
-32.98%139.33M
--5.51M
146.20%27.64M
Operating profit
8.20%-57.52M
60.71%-28.58M
-23.70%-76.28M
19.31%-49.59M
-14.15%-62.66M
-15.75%-72.75M
-12.34%-61.66M
-19.59%-61.45M
15.38%-54.89M
-66.37%-62.85M
-245.46%-54.89M
-512.07%-51.39M
-128.84%-64.87M
-146.32%-37.78M
234.31%37.73M
-19.38%-8.40M
42.31%224.95M
-49.27%81.55M
---28.10M
-723.54%-7.03M
Net Profit
5.38%-43.16M
73.85%-8.95M
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.53%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
-134.66%-2.32M
Current assets
-13.12%664.60M
-3.08%728.23M
-6.43%695.14M
-3.81%742.14M
-6.02%764.98M
-13.83%751.37M
-19.21%742.88M
-17.10%771.55M
-13.47%813.95M
-14.97%871.99M
-12.06%919.52M
-18.64%930.74M
-19.90%940.65M
10.29%1.03B
30.10%1.05B
32.40%1.14B
29.34%1.17B
14.32%929.80M
605.04%803.75M
--864.00M
Total current liabilities
-37.27%47.29M
-16.06%64.31M
-13.53%68.80M
-4.77%67.02M
-28.11%75.40M
-35.63%76.61M
-27.82%79.57M
-40.81%70.38M
17.07%104.88M
0.59%119.01M
3.95%110.24M
-46.23%118.91M
-58.02%89.59M
-1.95%118.32M
114.03%106.05M
217.01%221.14M
141.44%213.42M
16.61%120.68M
146.46%49.55M
--69.76M
Total assets
-2.76%1.31B
-0.26%1.36B
-2.64%1.36B
-0.74%1.40B
-8.13%1.34B
-8.57%1.36B
-7.89%1.39B
-8.11%1.41B
-2.32%1.46B
-3.43%1.49B
-2.59%1.51B
-3.55%1.54B
-5.93%1.50B
16.86%1.54B
32.38%1.55B
38.37%1.59B
41.09%1.59B
31.13%1.32B
723.63%1.17B
--1.15B
Total liabilities
14.88%369.03M
28.11%390.05M
24.54%391.95M
31.00%394.99M
-3.59%321.23M
-9.32%304.47M
-4.46%314.73M
-11.93%301.51M
15.12%333.18M
9.15%335.78M
8.99%329.42M
-10.13%342.34M
-24.78%289.42M
5.05%307.63M
37.80%302.24M
106.83%380.93M
124.49%384.78M
67.31%292.84M
312.69%219.34M
--184.18M
Total equity
-8.30%938.08M
-8.44%966.90M
-10.58%964.04M
-9.35%1.01B
-9.46%1.02B
-8.35%1.06B
-8.85%1.08B
-7.02%1.11B
-6.50%1.13B
-6.56%1.15B
-5.39%1.18B
-1.49%1.19B
0.08%1.21B
20.23%1.23B
31.13%1.25B
25.34%1.21B
26.16%1.21B
23.51%1.03B
968.37%953.40M
--967.68M
Net operating income
-190.14%-33.52M
-334.29%-34.74M
-82.10%-52.59M
-8.14%-32.40M
72.30%-11.55M
59.21%-8.00M
-27147.17%-28.88M
-250.56%-29.97M
5.34%-41.71M
-163.44%-19.61M
99.92%-106.00K
-92.71%19.90M
-143.97%-44.06M
284.97%30.91M
-2037.32%-126.79M
73.14%273.01M
-8.51%100.22M
-1409.32%-16.71M
---5.93M
--157.68M
Net investment
-416.08%-25.08M
110.45%75.14M
886.70%36.49M
-161.06%-31.81M
-73.47%7.94M
246.79%35.70M
128.92%3.70M
251.49%52.10M
119.99%29.91M
-42.55%-24.32M
95.47%-12.79M
-26.45%-34.39M
-467.32%-149.61M
-1385.03%-17.06M
-4.59%-281.99M
40.40%-27.20M
-66.49%-26.37M
98.94%-1.15M
---269.63M
---45.63M
Net financing
20.47%7.19M
-0.65%4.12M
134.40%7.37M
-227.31%-3.38M
110.88%5.97M
10.01%4.14M
-52.56%3.15M
532.70%2.65M
718.12%2.83M
978.80%3.77M
34994.74%6.63M
-64.28%419.00K
85.37%-458.00K
-80.97%349.00K
-102.12%-19.00K
123.11%1.17M
-102.92%-3.13M
-99.70%1.83M
--898.00K
---5.08M

FAQs

What is the total revenue of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its total revenue reached 75.13M, with a year-on-year change of 28.83M.

What are the current assets of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its current assets were 728.23M, with a year-on-year change of -3.08.

What are the total assets of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its total assets of Abcellera Biologics Inc were 1.36B, with a year-on-year change of -0.26.

What are the total liabilities of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its total liabilities of Abcellera Biologics Inc were 390.05M, with a year-on-year change of 28.11.

What is the total equity of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its total equity of Abcellera Biologics Inc was 966.90M, with a year-on-year change of -8.44.

What is the net operating income of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its net operating income of Abcellera Biologics Inc was -217.10M, with a year-on-year change of 13.42.

What is the net investment of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its net investment of Abcellera Biologics Inc was 87.75M, with a year-on-year change of -27.72.

What is the net financing of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its net financing of Abcellera Biologics Inc was 14.08M, with a year-on-year change of 10.28.

What is the Earnings Per Share (EPS) of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.49, with a year-on-year change of 11.42.

What is the net income of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its net income was -146.41M, with a year-on-year change of 10.10.

What is the net margin of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its net profit margin was -194.88, with a year-on-year change of 65.50.

What is the Return on Equity (ROE) of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its Return on Equity (ROE) was -14.47, with a year-on-year change of 1.86.

What is the Return on Assets (ROA) of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its Return on Assets (ROA) was -10.78, with a year-on-year change of 5.76.

What is the operating profit of Abcellera Biologics Inc?

According to Abcellera Biologics Inc's FY2025 earnings report, its operating profit was -217.10M, with a year-on-year change of 13.42.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.